Full Press Release Details
Comments on Unusual Market Activity
ONTARIO, April 7, 2026 - COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) ("COSCIENS" or the "Company")
is issuing this news release in response to unusual market activity. While the Company does not normally comment on market activity or
market speculation, the Company confirms that it is not aware of any material undisclosed information relating to the Company that would
account for the recent increase in trading activity in, and trading price of, the Company's common shares.
COSCIENS Biopharma Inc.
COSCIENS is a life science company focused on the development of natural, plant-based active ingredients, leveraging the Company's
proprietary manufacturing and extraction technologies to develop Avenanthramides and Beta Glucan active ingredients currently used in
leading skincare brands worldwide. The Company's common shares are listed on the TSX under the symbol "CSCI" and are
listed and posted for trading on the OTCQB Venture Market under the symbol "CSCIF". For more information, please visit
COSCIENS' website at www.cosciensbio.com.
CEO and Chairman of the Board